Ole_CNX CRISPR Therapeutics (NASDAQ:CRSP), a leader in the gene-editing revolution, has captivated the attention of scientists and investors alike and received much attention from investors like Cathy Wood. Over the past five years, the company has been on a rollercoaster ride with explosive growth, going from a promising scientific tool to a reality with tangible therapeutic applications. Dramatic breakthroughs, regulatory approvals, and, of course, volatile price movements have marked this journey. So, wh ...